In both DME and exudative ARMD patients, there was a significant systematic decrease in plasma VEGF concentrations after 7 days of treatment with bevacizumab, clearly indicating its penetration through all layers of the retina and entry into the systematic circulation This reduction persisted for 4 weeks after the injection with no significant differences in the reduction ratio. Here, VEGFA is linked to age-related macular degeneration.